Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol

NCT00701883 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Placebo
DRUG: MBX-8025
DRUG: MBX-8025
DRUG: Atorvastatin
DRUG: MBX-8025
DRUG: MBX-8025

Sponsor

Gilead Sciences